Cross-cultural adaptation to Argentine Spanish and validation of the High Level Mobility Assessment Tool in individuals with Parkinson’s disease
Objective: To translate and adapt the High-Level Mobility Assessment Tool (HiMAT) into Argentine Spanish and evaluate its psychometric properties in individuals with Parkinson's disease (PD).…Developing a Virtual Brick-Building Group for Veterans with Movement Disorders
Objective: To improve quality of life for Veterans with movement disorders by creating a virtual group using building bricks Background: Parkinson’s disease (PD) may cause…“Quality of Life of Caregivers Living with a Movement Disorder. A Comprehensive Approach.”
Objective: Exploring self-perceived health, quality of life, economic factors, and social-work aspect of caregivers of patients living with some type of movement disorder. Background: Caregivers…Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study
Objective: Evaluate quality of life (QoL) data from the Phase 3 randomized, active-controlled BouNDless study. Background: Pivotal data from the BouNDless study (NCT04006210) showed that…Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease
Objective: To measure how people with Parkinson's disease (PD) feel, function, and survive, derived from continuous recordings with a wearable ankle inertial device in a real-world…Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Signs of PD and Experiences of Daily Living
Objective: Evaluate the effect of investigational ND0612 on motor signs of PD and motor experiences of daily living (m-EDL), as assessed using the MDS-UPDRS. Background:…GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation
Objective: To study the potential disease-modifying properties of ambroxol in PD patients with a GBA1 mutation Background: The most common genetic risk factor for Parkinson’s…A Pilot Study of Intrajejunal Faecal Microbiota Transplant to Improve Motor Function in Patients with Parkinson’s Disease Treated with Levodopa-carbidopa Intestinal Gel: Preliminary Findings.
Objective: To determine whether faecal microbiota transplant (FMT) improves motor function in patients with Parkinson Disease (PD) treated with levodopa/carbidopa intestinal gel (LCIG). Background: Preliminary…Long-Term Evolution of Advanced Parkinson’s Disease Burden: Subgroup Analysis from the 24 Month International PROSPECT Observational Study
Objective: To evaluate the long-term evolution of clinical outcomes and treatment patterns in people with advanced Parkinson’s disease (PwaPD) whose symptoms are inadequately controlled by…Analgesic effect of electroacupuncture on Relieving pain in Parkinson’s disease and the mechanism based on rs-fMRI
Objective: To investigate whether electroacupuncture (EA) on the primary motor cortex could reduce pain in patients with PD and to explore the mechanism behind its…
- « Previous Page
- 1
- …
- 164
- 165
- 166
- 167
- 168
- …
- 436
- Next Page »